Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Alanine substitution of two arginines in amino terminus of V3 of SIV disrupts CD4 binding whereas a similar replacement of two amino acids, lysine and arginine, in the carboxyl half of V3 prevents binding of a neutralizing monoclonal antibody.

Javaherian K, Zuchowski L, Clark FT.

AIDS Res Hum Retroviruses. 1995 Sep;11(9):1101-5. Erratum in: AIDS Res Hum Retroviruses 1995 Nov;11(11):1427.

PMID:
8554907
[PubMed - indexed for MEDLINE]
2.
3.

Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.

Cole KS, Alvarez M, Elliott DH, Lam H, Martin E, Chau T, Micken K, Rowles JL, Clements JE, Murphey-Corb M, Montelaro RC, Robinson JE.

Virology. 2001 Nov 10;290(1):59-73.

PMID:
11883006
[PubMed - indexed for MEDLINE]
Free Article
4.

Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein.

Javaherian K, Langlois AJ, Montefiori DC, Kent KA, Ryan KA, Wyman PD, Stott J, Bolognesi DP, Murphey-Corb M, Larosa GJ.

J Virol. 1994 Apr;68(4):2624-31.

PMID:
7511176
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus.

Doyle CB, Bhattacharyya U, Kent KA, Stott JE, Jones IM.

J Virol. 1995 Feb;69(2):1256-60.

PMID:
7815501
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Strain specificity and binding affinity requirements of neutralizing monoclonal antibodies to the C4 domain of gp120 from human immunodeficiency virus type 1.

Nakamura GR, Byrn R, Wilkes DM, Fox JA, Hobbs MR, Hastings R, Wessling HC, Norcross MA, Fendly BM, Berman PW.

J Virol. 1993 Oct;67(10):6179-91.

PMID:
7690420
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?

Clements GJ, Price-Jones MJ, Stephens PE, Sutton C, Schulz TF, Clapham PR, McKeating JA, McClure MO, Thomson S, Marsh M, et al.

AIDS Res Hum Retroviruses. 1991 Jan;7(1):3-16.

PMID:
2015114
[PubMed - indexed for MEDLINE]
9.

Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies.

Kent KA, Rud E, Corcoran T, Powell C, Thiriart C, Collignon C, Stott EJ.

AIDS Res Hum Retroviruses. 1992 Jun;8(6):1147-51.

PMID:
1380261
[PubMed - indexed for MEDLINE]
10.

Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region.

Wyatt R, Thali M, Tilley S, Pinter A, Posner M, Ho D, Robinson J, Sodroski J.

J Virol. 1992 Dec;66(12):6997-7004.

PMID:
1279195
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.

Valenzuela A, Blanco J, Krust B, Franco R, Hovanessian AG.

J Virol. 1997 Nov;71(11):8289-98.

PMID:
9343181
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Effects of natural sequence variation on recognition by monoclonal antibodies neutralize simian immunodeficiency virus infectivity.

Choi WS, Collignon C, Thiriart C, Burns DP, Stott EJ, Kent KA, Desrosiers RC.

J Virol. 1994 Sep;68(9):5395-402.

PMID:
7520089
[PubMed - indexed for MEDLINE]
Free PMC Article
13.
15.

The V3 domain of SIVmac251 gp120 contains a linear neutralizing epitope.

Palker TJ, Muir AJ, Spragion DE, Staats HF, Langlois A, Montefiori DC.

Virology. 1996 Oct 15;224(2):415-26.

PMID:
8874502
[PubMed - indexed for MEDLINE]
Free Article
16.

Interactions among HIV gp120, CD4, and CXCR4: dependence on CD4 expression level, gp120 viral origin, conservation of the gp120 COOH- and NH2-termini and V1/V2 and V3 loops, and sensitivity to neutralizing antibodies.

Mondor I, Moulard M, Ugolini S, Klasse PJ, Hoxie J, Amara A, Delaunay T, Wyatt R, Sodroski J, Sattentau QJ.

Virology. 1998 Sep 1;248(2):394-405.

PMID:
9721247
[PubMed - indexed for MEDLINE]
Free Article
17.

The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.

Peet NM, McKeating JA, de Souza JB, Roitt IM, Delves PJ, Lund T.

Virology. 1998 Nov 10;251(1):59-70.

PMID:
9813203
[PubMed - indexed for MEDLINE]
Free Article
19.

Changes in the reactivity and neutralizing activity of a type-specific neutralizing monoclonal antibody induced by interaction of soluble CD4 with gp120.

Maeda Y, Matsushita S, Hattori T, Murakami T, Takatsuki K.

AIDS Res Hum Retroviruses. 1992 Dec;8(12):2049-54.

PMID:
1493053
[PubMed - indexed for MEDLINE]
20.

Production and characterization of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.

Babas T, Le Grand R, Dormont D, Bahraoui E.

AIDS Res Hum Retroviruses. 1997 Sep 1;13(13):1109-19.

PMID:
9282816
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk